Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gib Bogle

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos Computational Biology|October 26, 2018
An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroidsXinjian Mao, Sarah McManaway, Jagdish K Jaiswal, et al.
Frontiers in Pharmacology|October 4, 2018
Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell CulturesCho R Hong, Gib Bogle, Jingli Wang, et al.
Frontiers in Pharmacology|February 25, 2022
Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based ModellingVictoria Jackson-Patel, Emily Liu, Matthew R Bull, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2021
Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648Cho R Hong, Chantal D Buckley, Way W Wong, et al.
Cancer Research Communications|January 27, 2023
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T CellsStefan Milutinovic, Jun Abe, Emma Jones, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2021
Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrugCho Rong Hong, Sunali Y Mehta, H D Sarath Liyanage, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos Computational Biology|October 26, 2018
An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroidsXinjian Mao, Sarah McManaway, Jagdish K Jaiswal, et al.
Frontiers in Pharmacology|October 4, 2018
Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell CulturesCho R Hong, Gib Bogle, Jingli Wang, et al.
Frontiers in Pharmacology|February 25, 2022
Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based ModellingVictoria Jackson-Patel, Emily Liu, Matthew R Bull, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2021
Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648Cho R Hong, Chantal D Buckley, Way W Wong, et al.
Cancer Research Communications|January 27, 2023
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T CellsStefan Milutinovic, Jun Abe, Emma Jones, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2021
Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrugCho Rong Hong, Sunali Y Mehta, H D Sarath Liyanage, et al.
Pageof 2